mRNA |
ML006 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
AS601245 |
GDSC1000 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
-0.038 |
0.4 |
mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
0.039 |
0.4 |
mRNA |
OSI-027 |
GDSC1000 |
pan-cancer |
AAC |
-0.025 |
0.4 |